| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Johns Hopkins Oncology Center and the Program in Human Genetics and Molecular Biology, Baltimore, Maryland 21231 [T. W., K. W. K., B. V.], and The Howard Hughes Medical Institute, Baltimore, Maryland 21231 [B. V.]
DNA-damaging agents induce a p53-dependent G1 arrest that may be critical for p53-mediated tumor suppression. It has been suggested that p21WAF1/CIP1, a cdk inhibitory protein transcriptionally regulated by p53, is an effector of this arrest. To test this hypothesis, an isogenic set of human colon adenocarcinoma cell lines differing only in their p21 status was created. The parental cell line underwent the expected cell cycle changes upon induction of p53 expression by DNA damage, but the G1 arrest was completely abrogated in p21-deficient cells. These results unambiguously establish p21 as a critical mediator of one well-documented p53 function and have important implications for understanding cell cycle checkpoints and the mechanism(s) through which p53 inhibits human neoplasia.
1 This work was supported by NIH Grants CA43460 and GM07184. B. V. is an Investigator of the Howard Hughes Medical Institute.
2 To whom requests for reprints should be addressed, at The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231. Phone: (410) 955-8878; Fax (410) 955-0548.
Received 9/12/95. Accepted 10/ 5/95.
This article has been cited by other articles:
![]() |
Y. Li, L.-J. Li, S.-T. Zhang, L.-J. Wang, Z. Zhang, N. Gao, Y.-Y. Zhang, and Q.-M. Chen In vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Oral Leukoplakia Clin. Cancer Res., November 1, 2009; 15(21): 6724 - 6731. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Lim, S.-W. Chong, and Y.-J. Jiang Udu Deficiency Activates DNA Damage Checkpoint Mol. Biol. Cell, October 1, 2009; 20(19): 4183 - 4193. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gao, H. Inuzuka, M. Korenjak, A. Tseng, T. Wu, L. Wan, M. Kirschner, N. Dyson, and W. Wei Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways Mol. Biol. Cell, July 15, 2009; 20(14): 3305 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ubezio, M. Lupi, D. Branduardi, P. Cappella, E. Cavallini, V. Colombo, G. Matera, C. Natoli, D. Tomasoni, and M. D'Incalci Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities Cancer Res., June 15, 2009; 69(12): 5234 - 5240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Calvisi, H. Donninger, M. D. Vos, M. J. Birrer, L. Gordon, V. Leaner, and G. J. Clark NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 Cancer Res., June 1, 2009; 69(11): 4629 - 4637. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liu, N. Bellam, H.-Y. Lin, B. Wang, C. R. Stockard, W. E. Grizzle, and W.-C. Lin Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer Mol. Cell. Biol., May 15, 2009; 29(10): 2673 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Padmakumar, E. Aleem, C. Berthet, M. B. Hilton, and P. Kaldis Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53 Mol. Cell. Biol., May 15, 2009; 29(10): 2582 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mannefeld, E. Klassen, and S. Gaubatz B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells Cancer Res., May 1, 2009; 69(9): 4073 - 4080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Toettcher, A. Loewer, G. J. Ostheimer, M. B. Yaffe, B. Tidor, and G. Lahav Distinct mechanisms act in concert to mediate cell cycle arrest PNAS, January 20, 2009; 106(3): 785 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Song, Y. Wang, K. Kudo, E. J. Gavin, Y. Xi, and J. Ju miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit Clin. Cancer Res., December 15, 2008; 14(24): 8080 - 8086. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, L. Shu, and X. Chen Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival J. Biol. Chem., November 7, 2008; 283(45): 30689 - 30698. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Min, Y. J. Choi, H. R. Pyo, H. Kim, J. Seong, H. C. Chung, S. Y. Rha, and N. K. Kim Cyclooxygenase-2 Expression in Pretreatment Biopsy as a Predictor of Tumor Responses After Preoperative Chemoradiation in Rectal Cancer Arch Surg, November 1, 2008; 143(11): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodriguez, L. T. Hansen, G. Phear, J. Scorah, M. Spang-Thomsen, A. Cox, T. Helleday, and M. Meuth Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11 Clin. Cancer Res., September 1, 2008; 14(17): 5476 - 5483. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lazzarini, S. Moretti, S. Orecchia, P.-G. Betta, A. Procopio, and A. Catalano Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma Clin. Cancer Res., August 15, 2008; 14(16): 5099 - 5107. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Egler, S. Korur, M. Failly, J.-L. Boulay, R. Imber, M. M. Lino, and A. Merlo Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death Clin. Cancer Res., May 15, 2008; 14(10): 3132 - 3140. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ivanovska, A. S. Ball, R. L. Diaz, J. F. Magnus, M. Kibukawa, J. M. Schelter, S. V. Kobayashi, L. Lim, J. Burchard, A. L. Jackson, et al. MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression Mol. Cell. Biol., April 1, 2008; 28(7): 2167 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, Y. Zhong, Y. Wang, X. Zhang, D. L. Batista, R. Gejman, P. J. Ansell, J. Zhao, C. Weng, and A. Klibanski Activation of p53 by MEG3 Non-coding RNA J. Biol. Chem., August 24, 2007; 282(34): 24731 - 24742. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Scott, S. Nath-Sain, M. D. Agnew, and P. A. Marignani LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression Cancer Res., June 15, 2007; 67(12): 5622 - 5627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Giono and J. J. Manfredi Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest Mol. Cell. Biol., June 1, 2007; 27(11): 4166 - 4178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Michod and C. Widmann TAT-RasGAP317-326 Requires p53 and PUMA to Sensitize Tumor Cells to Genotoxins Mol. Cancer Res., May 1, 2007; 5(5): 497 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Donawho, Y. Luo, Y. Luo, T. D. Penning, J. L. Bauch, J. J. Bouska, V. D. Bontcheva-Diaz, B. F. Cox, T. L. DeWeese, L. E. Dillehay, et al. ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models Clin. Cancer Res., May 1, 2007; 13(9): 2728 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aneja, A. M. Ghaleb, J. Zhou, V. W. Yang, and H. C. Joshi p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells Cancer Res., April 15, 2007; 67(8): 3862 - 3870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hosokawa, A. Takehara, K. Matsuda, H. Eguchi, H. Ohigashi, O. Ishikawa, Y. Shinomura, K. Imai, Y. Nakamura, and H. Nakagawa Oncogenic Role of KIAA0101 Interacting with Proliferating Cell Nuclear Antigen in Pancreatic Cancer Cancer Res., March 15, 2007; 67(6): 2568 - 2576. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wang, J. Yu, and L. Zhang The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage PNAS, March 6, 2007; 104(10): 4054 - 4059. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liekens, S. Gijsbers, E. Vanstreels, D. Daelemans, E. De Clercq, and S. Hatse The Nucleotide Analog Cidofovir Suppresses Basic Fibroblast Growth Factor (FGF2) Expression and Signaling and Induces Apoptosis in FGF2-Overexpressing Endothelial Cells Mol. Pharmacol., March 1, 2007; 71(3): 695 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Barboza, G. Liu, Z. Ju, A. K. El-Naggar, and G. Lozano p21 delays tumor onset by preservation of chromosomal stability PNAS, December 26, 2006; 103(52): 19842 - 19847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lee, J.-S. Lee, S.-E. Kim, B.-S. Moon, Y.-C. Kim, S.-K. Lee, S.-K. Lee, and K.-Y. Choi Tautomycetin inhibits growth of colorectal cancer cells through p21cip/WAF1 induction via the extracellular signal-regulated kinase pathway Mol. Cancer Ther., December 1, 2006; 5(12): 3222 - 3231. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Saunders and E. Verdin Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Agarwal, K. Hastak, M. W. Jackson, S. N. Breit, G. R. Stark, and M. L. Agarwal Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors PNAS, October 31, 2006; 103(44): 16278 - 16283. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, R. B. Hamanaka, E. Bobrovnikova-Marjon, J. D. Gordan, M.-S. Dai, H. Lu, M. C. Simon, and J. A. Diehl Ribosomal Stress Couples the Unfolded Protein Response to p53-dependent Cell Cycle Arrest J. Biol. Chem., October 6, 2006; 281(40): 30036 - 30045. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aiello, G. Pandini, F. Frasca, E. Conte, A. Murabito, A. Sacco, M. Genua, R. Vigneri, and A. Belfiore Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells Endocrinology, September 1, 2006; 147(9): 4463 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hubert, S. Paris, J.-P. Piret, N. Ninane, M. Raes, and C. Michiels Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level J. Cell Sci., August 15, 2006; 119(16): 3351 - 3362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eckert, S. E. M. Meek, and K. L. Ball A Novel Repressor Domain Is Required for Maximal Growth Inhibition by the IRF-1 Tumor Suppressor J. Biol. Chem., August 11, 2006; 281(32): 23092 - 23102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chao, C.-M. Chen, P.-L. Cheng, J.-W. Shih, A.-P. Tsou, and Y.-H. Wu Lee DDX3, a DEAD Box RNA Helicase with Tumor Growth-Suppressive Property and Transcriptional Regulation Activity of the p21waf1/cip1 Promoter, Is a Candidate Tumor Suppressor. Cancer Res., July 1, 2006; 66(13): 6579 - 6588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rossi, R. Mukerjee, P. Ferrante, K. Khalili, S. Amini, and B. E. Sawaya Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes J. Gen. Virol., June 1, 2006; 87(6): 1613 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xi, R. Shalgi, O. Fodstad, Y. Pilpel, and J. Ju Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer. Clin. Cancer Res., April 1, 2006; 12(7): 2014 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Menendez, O. Krysiak, A. Inga, B. Krysiak, M. A. Resnick, and G. Schonfelder A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network PNAS, January 31, 2006; 103(5): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Archer, J. Johnson, H.-J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G696 - G703. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Shen, H. Heng, Y. Wang, S. Lu, G. Liu, C.-X. Deng, S.C. Brooks, and Y. A. Wang ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development Cancer Res., October 1, 2005; 65(19): 8747 - 8753. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-V. Le, A. J. Minn, and J. Massague Cyclin-dependent Kinase Inhibitors Uncouple Cell Cycle Progression from Mitochondrial Apoptotic Functions in DNA-damaged Cancer Cells J. Biol. Chem., September 9, 2005; 280(36): 32018 - 32025. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Xu, G. Perez, L. Ngo, C.-Y. Gui, and P. A. Marks Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects Cancer Res., September 1, 2005; 65(17): 7832 - 7839. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Arva, T. R. Gopen, K. E. Talbott, L. E. Campbell, A. Chicas, D. E. White, G. L. Bond, A. J. Levine, and J. Bargonetti A Chromatin-associated and Transcriptionally Inactive p53-Mdm2 Complex Occurs in mdm2 SNP309 Homozygous Cells J. Biol. Chem., July 22, 2005; 280(29): 26776 - 26787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gartel and S. K. Radhakrishnan Lost in Transcription: p21 Repression, Mechanisms, and Consequences Cancer Res., May 15, 2005; 65(10): 3980 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Arbel-Goren, Y. Levy, D. Ronen, and Y. Zick Cyclin-dependent Kinase Inhibitors and JNK Act as Molecular Switches, Regulating the Choice between Growth Arrest and Apoptosis Induced by Galectin-8 J. Biol. Chem., May 13, 2005; 280(19): 19105 - 19114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Aguero, M. M. Facchinetti, Z. Sheleg, and A. M. Senderowicz Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1 Cancer Res., April 15, 2005; 65(8): 3364 - 3373. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Normand, P. G. Hemmati, B. Verdoodt, C. von Haefen, J. Wendt, D. Guner, E. May, B. Dorken, and P. T. Daniel p14ARF Induces G2 Cell Cycle Arrest in p53- and p21-deficient Cells by Down-regulating p34cdc2 Kinase Activity J. Biol. Chem., February 25, 2005; 280(8): 7118 - 7130. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Choi, E. W. Gerner, L. Ramdas, J. Dupart, J. Carew, L. Proctor, P. Huang, W. Zhang, and S. R. Hamilton Combination of 5-Fluorouracil and N1,N11-Diethylnorspermine Markedly Activates Spermidine/Spermine N1-Acetyltransferase Expression, Depletes Polyamines, and Synergistically Induces Apoptosis in Colon Carcinoma Cells J. Biol. Chem., February 4, 2005; 280(5): 3295 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoon and R. C. Smart C/EBP{alpha} Is a DNA Damage-Inducible p53-Regulated Mediator of the G1 Checkpoint in Keratinocytes Mol. Cell. Biol., December 15, 2004; 24(24): 10650 - 10660. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-h. Meng, H. Zhang, L. Hayward, H. Takemura, R.-G. Shao, and Y. Pommier Tetrandrine Induces Early G1 Arrest in Human Colon Carcinoma Cells by Down-Regulating the Activity and Inducing the Degradation of G1-S-Specific Cyclin-Dependent Kinases and by Inducing p53 and p21Cip1 Cancer Res., December 15, 2004; 64(24): 9086 - 9092. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, and C. A. Stein Relative Bcl-2 Independence of Drug-Induced Cytotoxicity and Resistance in 518A2 Melanoma Cells Clin. Cancer Res., December 15, 2004; 10(24): 8371 - 8379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amini, M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes J. Biol. Chem., October 29, 2004; 279(44): 46046 - 46056. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Rorie and B. E. Weissman The Ews/Fli-1 Fusion Gene Changes the Status of p53 in Neuroblastoma Tumor Cell Lines Cancer Res., October 15, 2004; 64(20): 7288 - 7295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song, J. Cooperman, D. L. Letting, G. A. Blobel, and J. K. Choi Identification of Cyclin D3 as a Direct Target of E2A Using DamID Mol. Cell. Biol., October 1, 2004; 24(19): 8790 - 8802. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, J.-S. Kim, and T. Waldman PTEN Gene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer Cells Cancer Res., October 1, 2004; 64(19): 6906 - 6914. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Amundson, M. B. Grace, C. B. McLeland, M. W. Epperly, A. Yeager, Q. Zhan, J. S. Greenberger, and A. J. Fornace Jr. Human In vivo Radiation-Induced Biomarkers: Gene Expression Changes in Radiotherapy Patients Cancer Res., September 15, 2004; 64(18): 6368 - 6371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bai, H. Nakamura, S. Ueda, Y.-W. Kwon, T. Tanaka, S. Ban, and J. Yodoi Proteasome-dependent Degradation of Cyclin D1 in 1-Methyl-4-phenylpyridinium Ion (MPP+)-induced Cell Cycle Arrest J. Biol. Chem., September 10, 2004; 279(37): 38710 - 38714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Geller, K. Szekely-Szucs, I. Petak, B. Doyle, and J. A. Houghton P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells Cancer Res., September 1, 2004; 64(17): 6296 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guweidhi, J. Kleeff, N. Giese, J. E. Fitori, K. Ketterer, T. Giese, M. W. Buchler, M. Korc, and H. Friess Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis Carcinogenesis, September 1, 2004; 25(9): 1575 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels PNAS, May 11, 2004; 101(19): 7386 - 7391. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Tu, T. Melendy, and T. A. Beerman DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic Mol. Cancer Ther., May 1, 2004; 3(5): 577 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Shariat, H. Tokunaga, J. Zhou, J. Kim, G. E. Ayala, W. F. Benedict, and S. P. Lerner p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer J. Clin. Oncol., March 15, 2004; 22(6): 1014 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. A. LaRue, M. Khalil, and J. P. Freyer Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors Cancer Res., March 1, 2004; 64(5): 1621 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prince, S. Carreira, K. W. Vance, A. Abrahams, and C. R. Goding Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor Cancer Res., March 1, 2004; 64(5): 1669 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kim, S. Kook, D. J. Kim, C. Teodorof, and W. K. Song The 31-kDa Caspase-generated Cleavage Product of p130cas Functions as a Transcriptional Repressor of E2A in Apoptotic Cells J. Biol. Chem., February 27, 2004; 279(9): 8333 - 8342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Yoon and V. W. Yang Requirement of Kruppel-like Factor 4 in Preventing Entry into Mitosis following DNA Damage J. Biol. Chem., February 6, 2004; 279(6): 5035 - 5041. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wajapeyee and K. Somasundaram Cell Cycle Arrest and Apoptosis Induction by Activator Protein 2{alpha} (AP-2{alpha}) and the Role of p53 and p21WAF1/CIP1 in AP-2{alpha}-mediated Growth Inhibition J. Biol. Chem., December 26, 2003; 278(52): 52093 - 52101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, X.-W. Liu, and H.-R. C. Kim Platelet-derived Growth Factor (PDGF) Receptor-{alpha}-activated c-Jun NH2-terminal Kinase-1 Is Critical for PDGF-induced p21WAF1/CIP1 Promoter Activity Independent of p53 J. Biol. Chem., December 5, 2003; 278(49): 49582 - 49588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maitra, D. E. Hansel, P. Argani, R. Ashfaq, A. Rahman, A. Naji, S. Deng, J. Geradts, L. Hawthorne, M. G. House, et al. Global Expression Analysis of Well-Differentiated Pancreatic Endocrine Neoplasms Using Oligonucleotide Microarrays Clin. Cancer Res., December 1, 2003; 9(16): 5988 - 5995. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishizuka, K. Martin, C. Booth, C. S. Potten, G. de Murcia, A. Burkle, and T. B. L. Kirkwood Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo Nucleic Acids Res., November 1, 2003; 31(21): 6198 - 6205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ukomadu and A. Dutta p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent Kinases J. Biol. Chem., October 31, 2003; 278(44): 43586 - 43594. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Su, S. Ishikawa, M. Kojima, and B. Liu Eradication of pathogenic {beta}-catenin by Skp1/Cullin/F box ubiquitination machinery PNAS, October 28, 2003; 100(22): 12729 - 12734. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, J.-Y. Zhou, Y. Ge, L. H. Matherly, and G. S. Wu The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation J. Biol. Chem., October 17, 2003; 278(42): 41059 - 41068. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Barnes, M. J. Kellum, K. E. Pinder, J. A. Frisancho, and P. M. Pitha Interferon Regulatory Factor 5, a Novel Mediator of Cell Cycle Arrest and Cell Death Cancer Res., October 1, 2003; 63(19): 6424 - 6431. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Padova, T. Bruno, F. De Nicola, S. Iezzi, C. D'Angelo, R. Gallo, D. Nicosia, N. Corbi, A. Biroccio, A. Floridi, et al. Che-1 Arrests Human Colon Carcinoma Cell Proliferation by Displacing HDAC1 from the p21WAF1/CIP1 Promoter J. Biol. Chem., September 19, 2003; 278(38): 36496 - 36504. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bai, J. H. Xi, E. F. Wawrousek, T. P. Fleming, and U. P. Andley Hyperproliferation and p53 Status of Lens Epithelial Cells Derived from {alpha}B-crystallin Knockout Mice J. Biol. Chem., September 19, 2003; 278(38): 36876 - 36886. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nowak, P. M. Price, and R. G. Schnellmann Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells Am J Physiol Renal Physiol, September 1, 2003; 285(3): F440 - F450. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, H. O. Weber, J. G. Hengstler, M.-E. Halatsch, M. Volm, K. D. Tew, et al. Molecular Modes of Action of Artesunate in Tumor Cell Lines Mol. Pharmacol., August 1, 2003; 64(2): 382 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zeng, Y. Zhang, S. Chien, X. Liu, and J. Y.-J. Shyy The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow J. Biol. Chem., June 27, 2003; 278(27): 24594 - 24599. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T.V. Le and D. R. Richardson Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation Carcinogenesis, June 1, 2003; 24(6): 1045 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Jallepalli, C. Lengauer, B. Vogelstein, and F. Bunz The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells J. Biol. Chem., May 30, 2003; 278(23): 20475 - 20479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn, M. Urist, and C. Prives Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response J. Biol. Chem., May 30, 2003; 278(23): 20480 - 20489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Douglas and G. G. Haddad Genetic Models in Applied Physiology: Invited Review: Effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest J Appl Physiol, May 1, 2003; 94(5): 2068 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Braastad, Z. Han, and E. A. Hendrickson Constitutive DNase I Hypersensitivity of p53-Regulated Promoters J. Biol. Chem., February 28, 2003; 278(10): 8261 - 8268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, Z. Wang, K. W. Kinzler, B. Vogelstein, and L. Zhang PUMA mediates the apoptotic response to p53 in colorectal cancer cells PNAS, February 18, 2003; 100(4): 1931 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Yang, J.-X. Pan, L. Sun, and S.-C. J. Yeung p21 Waf-1 (Cip-1) Enhances Apoptosis Induced by Manumycin and Paclitaxel in Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 763 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wang, J. Gu, K. Judson-Kremer, K.L. Powell, H. Mistry, P. Simhambhatla, C. M. Aldaz, S. Gaddis, and M. C. MacLeod Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways Carcinogenesis, February 1, 2003; 24(2): 225 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Yoon, X. Chen, and V. W. Yang Kruppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage J. Biol. Chem., January 17, 2003; 278(4): 2101 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Polager and D. Ginsberg E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress J. Biol. Chem., January 10, 2003; 278(3): 1443 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Polek, L. V. Stewart, E. J. Ryu, M. B. Cohen, E. A. Allegretto, and N. L. Weigel p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells Endocrinology, January 1, 2003; 144(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Russo, D. Arzani, S. Trombino, and C. Falugi c-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 37 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. McPherson, A. V. Loktev, and R. J. Weigel Tumor Suppressor Activity of AP2alpha Mediated through a Direct Interaction with p53 J. Biol. Chem., November 15, 2002; 277(47): 45028 - 45033. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mauser, S.'i. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney The Epstein-Barr Virus Immediate-Early Protein BZLF1 Regulates p53 Function through Multiple Mechanisms J. Virol., November 13, 2002; 76(24): 12503 - 12512. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Martinez, I. Naguibneva, H. Lehrmann, A. Vervisch, T. Tchenio, G. Lozano, and A. Harel-Bellan Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways PNAS, November 12, 2002; 99(23): 14849 - 14854. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, X. Shi, Q.-J. Zhang, M. Hampong, H. Paddon, D. Wahyuningsih, and S. Pelech Nocodazole-induced p53-dependent c-Jun N-terminal Kinase Activation Reduces Apoptosis in Human Colon Carcinoma HCT116 Cells J. Biol. Chem., November 8, 2002; 277(46): 43648 - 43658. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leger and E. A. Drobetsky Modulation of the DNA damage response in UV-exposed human lymphoblastoid cells through genetic-versus functional-inactivation of the p53 tumor suppressor Carcinogenesis, October 1, 2002; 23(10): 1631 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Pan, W.-J. Chen, S.-Y. Lin-Shiau, C.-T. Ho, and J.-K. Lin Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells Carcinogenesis, October 1, 2002; 23(10): 1677 - 1684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Megyesi, L. Andrade, J. M. Vieira Jr., R. L. Safirstein, and P. M. Price Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure Am J Physiol Renal Physiol, October 1, 2002; 283(4): F810 - F816. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Javelaud and F. Besancon Inactivation of p21WAF1Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio J. Biol. Chem., September 27, 2002; 277(40): 37949 - 37954. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |